{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Patient-Specific Instrumentation in Total Knee Arthroplasty"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Forty patients were randomised into two groups"
      },
      "Participants": {
        "score": 2,
        "evidence": "Eligibility criteria included patients scheduled for primary TKA. The study was conducted at a single orthopedic center."
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomised into two groups: PSI and conventional instrumentation"
      },
      "Objective": {
        "score": 1,
        "evidence": "This randomised controlled trial aimed to evaluate whether patient-specific instrumentation (PSI) in total knee arthroplasty (TKA) improves patient-reported outcomes and gait compared to conventional instrumentation."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was walking speed, measured using a 3-D gait analysis system, with a clinically important difference set at 0.1 m/second."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was performed using a computer-generated sequence, and allocation was concealed using sealed envelopes."
      },
      "Blinding": {
        "score": 1,
        "evidence": "Blinding was applied to outcome assessors."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Forty patients were randomised into two groups"
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "All 40 patients completed the study and were analyzed using an intention-to-treat approach."
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "Both groups showed improvements in functional scores, quality of life, and gait parameters. However, no significant differences were found between the PSI and conventional groups in KSS, KOOS, SF-12, or gait parameters."
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were reported."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: [Registration number]."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: [Source of funding]."
      }
    },
    "total_score": 18,
    "max_score": 25
  },
  "model": "gpt-4o"
}